Xenon Pharmaceuticals
XENE
XENE
158 hedge funds and large institutions have $2.37B invested in Xenon Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more capital invested
Capital invested by funds: $1.96B → $2.37B (+$408M)
3% more funds holding
Funds holding: 153 → 158 (+5)
3.22% more ownership
Funds ownership: 93.36% → 96.58% (+3.2%)
Holders
158
Holding in Top 10
12
Calls
$15.3M
Puts
$5.16M
Top Buyers
| 1 | +$26.7M | |
| 2 | +$19M | |
| 3 | +$18M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$15.8M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$15.1M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$18.2M | |
| 3 | -$17.5M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$9.84M |
| 5 |
PA
Perceptive Advisors
New York
|
-$7.94M |